Literature DB >> 11025869

Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study.

C N Bairey Merz1, M Olson, S McGorray, D L Pakstis, K Zell, C R Rickens, S F Kelsey, V Bittner, B L Sharaf, G Sopko.   

Abstract

Physical activity and functional capacity have not been assessed by questionnaire for criterion validity in women. We wished to evaluate the ability of a physical activity and a functional capacity assessment questionnaire to predict functional capacity measured by treadmill exercise stress testing, as well as correlate with cardiac risk factors and angiographic coronary artery disease (CAD) in women. In a National Heart, Lung and Blood Institute (NHLBI)-sponsored cross-sectional population study involving four academic medical centers, 476 women with cardiac risk factors undergoing coronary angiography for evaluation for suspected myocardial ischemia were enrolled in the Women's Ischemia Syndrome Evaluation (WISE). The main outcome measures were functional capacity measured during symptom-limited exercise treadmill testing, cardiac risk factors, and CAD, using core laboratory-determined measures. Physical activity measured by the Postmenopausal Estrogen and Progesterone Intervention physical activity questionnaire (PEPI-Q) and functional capacity measured by the Duke Activity Status Index (DASI) questionnaire, correlated with functional capacity measured in metabolic equivalents (METS), as estimated during symptom-limited exercise treadmill testing (r = 0.27, p = 0.001 and r = 0.31, p = 0. 0002, respectively). The DASI was a significant independent predictor of functional capacity even after adjustment for cardiac risk factors, and the PEPI-Q was not. The DASI and PEPI-Q scores were inversely associated with higher numbers and levels of cardiac risk factors, as well as angiographic CAD. The DASI questionnaire is a reasonable correlate of functional capacity achieved during symptom-limited treadmill exercise testing in women with suspected myocardial ischemia. Lower functional capacity or physical activity measured by the DASI and PEPI-Q, respectively, is associated with more prevalent cardiac risk factors and angiographic CAD. These findings suggest that the DASI and, to a lesser extent, the PEPI-Q have criterion validity for use in health-related research in women.

Entities:  

Mesh:

Year:  2000        PMID: 11025869     DOI: 10.1089/15246090050147745

Source DB:  PubMed          Journal:  J Womens Health Gend Based Med        ISSN: 1524-6094


  14 in total

Review 1.  Limits to the measurement of habitual physical activity by questionnaires.

Authors:  R J Shephard
Journal:  Br J Sports Med       Date:  2003-06       Impact factor: 13.800

2.  Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index.

Authors:  Vichai Senthong; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  Am Heart J       Date:  2016-10-20       Impact factor: 4.749

3.  Health-Related Quality of Life, Functional Status, and Cardiac Event-Free Survival in Patients With Heart Failure.

Authors:  Jia-Rong Wu; Terry A Lennie; Susan K Frazier; Debra K Moser
Journal:  J Cardiovasc Nurs       Date:  2016 May-Jun       Impact factor: 2.083

4.  Degree and correlates of cardiac knowledge and awareness among cardiac inpatients.

Authors:  Sheena Kayaniyil; Chris I Ardern; Jane Winstanley; Cynthia Parsons; Stephanie Brister; Paul Oh; Donna E Stewart; Sherry L Grace
Journal:  Patient Educ Couns       Date:  2008-10-25

5.  Development and evaluation of a treadmill-based exercise tolerance test in cardiac rehabilitation.

Authors:  Julie Dunagan; Jenny Adams; Dunlei Cheng; Stephanie Barton; Janet Bigej-Cerqua; Lisa Mims; Jennifer Molden; Valerie Anderson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-07

6.  Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.

Authors:  Patricia A Ganz; Edward H Romond; Reena S Cecchini; Priya Rastogi; Charles E Geyer; Sandra M Swain; Jong-Hyeon Jeong; Louis Fehrenbacher; Howard M Gross; Adam M Brufsky; Patrick J Flynn; Tanya A Wahl; Thomas E Seay; James L Wade; David D Biggs; James N Atkins; Jonathan Polikoff; John L Zapas; Eleftherios P Mamounas; Norman Wolmark
Journal:  J Clin Oncol       Date:  2017-10-26       Impact factor: 44.544

7.  Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women.

Authors:  May Bakir; Janet Wei; Michael D Nelson; Puja K Mehta; Afsaneh Haftbaradaran; Erika Jones; Edward Gill; Behzad Sharif; Piotr J Slomka; Debiao Li; Chrisandra L Shufelt; Margo Minissian; Daniel S Berman; C Noel Bairey Merz; Louise E J Thomson
Journal:  Cardiovasc Diagn Ther       Date:  2016-02

8.  The joint impact of smoking and exercise capacity on clinical outcomes among women with suspected myocardial ischemia: the WISE study.

Authors:  Sarah E Linke; Thomas Rutledge; B Delia Johnson; Marian B Olson; Vera Bittner; Carol E Cornell; Leslee J Shaw; Wafia Eteiba; Susmita Parashar; David S Sheps; Diane A Vido; Suresh Mulukutla; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2009-04       Impact factor: 2.681

9.  Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Leslee J Shaw; C Noel Bairey Merz; Vera Bittner; Kevin Kip; B Delia Johnson; Steven E Reis; Sheryl F Kelsey; Marian Olson; Sunil Mankad; Barry L Sharaf; William J Rogers; Gerald M Pohost; George Sopko; Carl J Pepine
Journal:  J Womens Health (Larchmt)       Date:  2008-09       Impact factor: 2.681

Review 10.  The role of pharmacological stress testing in women.

Authors:  Katherine Standbridge; Eliana Reyes
Journal:  J Nucl Cardiol       Date:  2016-08-11       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.